Alberto Zambon speaks about the management of dyslipidemia with combination therapies, across different topics:

• Expected clinical benefits of LDL-C lowering therapies
• Euroaspire surveys IV-V
• Patterns of statin use in a real-world population of patients at high CV risk
• Results of a meta-analysis of 8 statin trials
• Efficacy of ezetimibe in lowering LDL-C vs doubling dose of statin in high risk previously treated statin patients: systematic review and networks meta-analysis
• Pattern of statin use in a real-world population of patients at high cardiovascular risk
• Association of combined measure of adherence and treatment intensity with cardiovascular outcomes in patients with atherosclerosis or other cardiovascular risk factors treated with statins and/or ezetimibe

The presentation closes with results about adherence to statin therapy in patients hospitalized for ACS at the Padua University Hospital.